Open Access

Risk of endometrial cancer in patients with polycystic ovarian syndrome: A meta‑analysis

  • Authors:
    • Jean-Ellen Johnson
    • Diandra Daley
    • Cristi Tarta
    • Paul I. Stanciu
  • View Affiliations

  • Published online on: March 8, 2023     https://doi.org/10.3892/ol.2023.13754
  • Article Number: 168
  • Copyright: © Johnson et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

While existing literature suggests an association between polycystic ovarian syndrome (PCOS) and endometrial cancer, the sparsity and inconsistency of current evidence indicates a lack of clarity regarding the exact strength of this association. It also remains uncertain whether the degree of risk of disease is affected by confounding factors, such as age and body mass index (BMI). The present meta‑analysis is aimed to quantify the risk of endometrial cancer in female subjects with PCOS compared to those without PCOS. PubMed, MEDLINE, EMBASE, Scopus and Cochrane were searched from inception to October 31, 2022, to identify peer‑reviewed case‑control, cohort and cross‑sectional studies that assessed the association between endometrial cancer and PCOS and contained original data. Two researchers independently extracted data and performed quality assessment using the Newcastle‑Ottawa criteria. Pooled odds ratios (ORs) were calculated using the random‑effect model and inverse variance. The degree of heterogeneity was assessed using I² statistics. A total of 10 relevant studies were identified and included in the meta‑analysis (comprising 12,248 female patients with PCOS and 54,120 controls). Females with PCOS had a significantly increased odds of developing endometrial cancer as compared to those without PCOS [OR, 4.07; 95% confidence interval (CI), 2.13‑7.78; P<0.0001]. When postmenopausal subjects (age, >54 years) were excluded from the meta‑analysis, the odds increased further (OR, 5.14; 95% CI, 3.22‑8.21; P<0.00001). Patients with PCOS are up to 5 times more likely to develop endometrial cancer compared to those without PCOS. Larger, prospective studies that are well‑controlled for confounding factors, such as BMI, are required.
View Figures
View References

Related Articles

Journal Cover

April-2023
Volume 25 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Johnson J, Daley D, Tarta C and Stanciu PI: Risk of endometrial cancer in patients with polycystic ovarian syndrome: A meta‑analysis. Oncol Lett 25: 168, 2023
APA
Johnson, J., Daley, D., Tarta, C., & Stanciu, P.I. (2023). Risk of endometrial cancer in patients with polycystic ovarian syndrome: A meta‑analysis. Oncology Letters, 25, 168. https://doi.org/10.3892/ol.2023.13754
MLA
Johnson, J., Daley, D., Tarta, C., Stanciu, P. I."Risk of endometrial cancer in patients with polycystic ovarian syndrome: A meta‑analysis". Oncology Letters 25.4 (2023): 168.
Chicago
Johnson, J., Daley, D., Tarta, C., Stanciu, P. I."Risk of endometrial cancer in patients with polycystic ovarian syndrome: A meta‑analysis". Oncology Letters 25, no. 4 (2023): 168. https://doi.org/10.3892/ol.2023.13754